EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Controlling pulsed field ablation efficacy during ablation procedures

María Cespón-Fernández iD, Rafael V Davalos iD, Thomas Kueffer iD, Bakhtawar Khan Mahmoodi iD, Tobias Reichlin iD, Andrea Sarkozy iD, Sing-Chien Yap iD, Edward J Jacobs iD, Guillaume Gibert iD, Samuel J Asirvatham iD

Europace · 2026

DOI: 10.1093/europace/euag188 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Europace, 2026. Verfasst von María Cespón-Fernández und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Department of Cardiology, Hospital Álvaro Cunqu…. Hauptthemen laut MEDLINE: Arrhythmias, Cardiac, Catheter Ablation. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boston Scientific.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulsed field ablation (PFA) has rapidly emerged as a promising ablation modality for the treatment of cardiac arrhythmias because of its myocardial tissue preferential ablation and favourable safety profile. However, procedural control of lesion formation and reliable assessment of lesion durability remain important challenges. This review summarizes the main determinants of PFA efficacy and current approaches for intraprocedural lesion assessment. Experimental and clinical studies indicate that PFA lesion formation results from the interaction between delivered electrical energy, catheter design, tissue coupling, and application strategy. Lesion size and geometry are primarily determined by electric field distribution and cumulative electroporation exposure, while excessive energy delivery may induce unwanted thermal or electrochemical effects. Procedural efficacy also depends on stable catheter positioning, adequate tissue proximity, and sufficient lesion overlap. Unlike thermal ablation technologies, conventional procedural markers such as electrogram attenuation, impedance changes, and pacing threshold variation correlate poorly with durable irreversible electroporation. Multiparametric lesion estimation models integrating electrical, mechanical, and positional data have shown encouraging preclinical results, although clinical validation remains limited. Emerging strategies combining electroanatomical mapping, imaging, and automated electrogram analysis may improve real-time evaluation of lesion continuity and durability. Current PFA workflows rely mainly on standardized energy delivery protocols, optimized catheter positioning, and lesion overlap rather than real-time titration of energy. Although robust intraprocedural markers of irreversible electroporation are still lacking, ongoing advances in catheter technology, imaging, and lesion assessment tools are expected to improve procedural reproducibility and long-term lesion durability. Further studies are needed to establish validated endpoints for durable PFA lesion formation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arrhythmias, CardiacCatheter AblationHumansIrreversible Electroporation TherapyTreatment OutcomeAnimals

Stichwörter der Autor:innen

Ablation indexesAtrial fibrillationCatheter ablationContact assessmentElectroanatomical mappingElectrogram analysisIntracardiac echocardiographyIrreversible electroporationLesion durabilityPulsed field ablationReversible electroporation

Autor:innen und Institutionen

  • Cardiovascular Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Department of Cardiology, Hospital Álvaro Cunqueiro, University of Vigo, Vigo, Spain.
  • Wallace H. Coulter Department of Biomedical Engineering, Georgia Tech - Emory University, Atlanta, GA, USA.
  • Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Cardiology, Thorax Center, Cardiovascular Institute, Erasmus MC, Rotterdam, the Netherlands.
  • Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel - Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Brussels, Belgium.
  • Electrophysiology Department, Boston Scientific Corporation, Marlborough, MA, USA.

ORCID-Profile: María Cespón-Fernández, Rafael V Davalos, Thomas Kueffer, Bakhtawar Khan Mahmoodi, Tobias Reichlin, Andrea Sarkozy, Sing-Chien Yap, Edward J Jacobs, Guillaume Gibert, Samuel J Asirvatham

Förderung

  • Boston Scientific

Zitieren

APA

Cespón-Fernández, M., Davalos, R. V., Kueffer, T., Khan Mahmoodi, B., Reichlin, T., Sarkozy, A., Yap, S. C., Jacobs, E. J., Gibert, G., & Asirvatham, S. J. (2026). Controlling pulsed field ablation efficacy during ablation procedures. Europace. https://doi.org/10.1093/europace/euag188

Vancouver

Cespón-Fernández M, Davalos RV, Kueffer T, Khan Mahmoodi B, Reichlin T, Sarkozy A, et al. Controlling pulsed field ablation efficacy during ablation procedures. Europace. 2026. doi:10.1093/europace/euag188

BibTeX
@article{CespnFernndez2026,
  author = {Cespón-Fernández, María and Davalos, Rafael V and Kueffer, Thomas and Khan Mahmoodi, Bakhtawar and Reichlin, Tobias and Sarkozy, Andrea and Yap, Sing-Chien and Jacobs, Edward J and Gibert, Guillaume and Asirvatham, Samuel J},
  title = {Controlling pulsed field ablation efficacy during ablation procedures},
  journal = {Europace},
  year = {2026},
  doi = {10.1093/europace/euag188}
}
Kostenlos starten →